MAK Capital key facts
- MAK Capital is a hedge fund based in New York, New York with 3 tracked portfolio companies.
- Notable positions include Noveome Biotherapeutics, Trailhead Biosystems, MARABio.
- MAK Capital reports $76.8M in regulatory assets under management across 2 private funds, per its SEC Form ADV (2026-03).
About MAK Capital
32402-44P
Investment focus
Its SEC Form ADV lists $76.8 million in regulatory assets under management across 2 private funds (Mar 2026).
MAK Capital portfolio at a glance
3 portfolio companies are on record for MAK Capital: Noveome Biotherapeutics, Trailhead Biosystems and MARABio.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
MAK Capital at the SEC
Form ADV · 2026-03 · CRD 158132- Regulatory AUM
- $76.8M
- Private fund assets
- $2.0B
- Private funds
- 2 · 1 private equity, 1 hedge
- Staff
- 12
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as MAK CAPITAL ONE, LLC).
Free account
See more of the book
- ·Watchlist + alerts for MAK Capital's activity
Portfolio
3 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Noveome Biotherapeutics | — | ▮ | ▮ | ▮ |
| Trailhead Biosystems | — | ▮ | ▮ | ▮ |
| MARABio | — | ▮ | ▮ | ▮ |
All 3 companies — valuations, dates and lead flags are a member feature Membership and data by Private Market View | ||||
Frequently asked about MAK Capital
- What companies does MAK Capital invest in?
- MAK Capital has 3 recorded portfolio companies, including Noveome Biotherapeutics, Trailhead Biosystems, MARABio.
- What is MAK Capital's AUM?
- MAK Capital manages approximately $76.8M in assets.